Oncogenic Ras and B-Raf Proteins Positively Regulate Death Receptor 5 Expression through Co-activation of ERK and JNK Signaling
Open Access
- 1 January 2012
- journal article
- Published by Elsevier
- Vol. 287 (1), 257-267
- https://doi.org/10.1074/jbc.m111.304006
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The Odyssey of K-RasMolecular Cell, 2006
- PKC Regulates a Farnesyl-Electrostatic Switch on K-Ras that Promotes its Association with Bcl-Xl on Mitochondria and Induces ApoptosisMolecular Cell, 2006
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Phosphorylated FADD induces NF-κB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomasProceedings of the National Academy of Sciences, 2005
- Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/Enhancer-Binding Protein Homologous ProteinCancer Research, 2005
- Transcription Factor NF-κB Differentially Regulates Death Receptor 5 Expression Involving Histone Deacetylase 1Molecular and Cellular Biology, 2005
- Transformation by Oncogenic RAS Sensitizes Human Colon Cells to TRAIL-induced Apoptosis by Up-regulating Death Receptor 4 and Death Receptor 5 through a MEK-dependent PathwayJournal of Biological Chemistry, 2005
- Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer CellsJNCI Journal of the National Cancer Institute, 2004
- Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.1997
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997